Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
Items 1–5 — Disease Prevention & Health Promotion
1)
Reference — Topic: Disease Prevention & Health Promotion —
Section: Adult Immunization Decisions (preventive counseling
and vaccine prioritization)
Question Stem
,A 68-year-old man with COPD presents for routine care in
October. He received an inactivated influenza vaccine last year.
Which of the following is the most appropriate immunization
recommendation today?
Options
A. No influenza vaccine this season because he had one last
year.
B. Give the current season’s inactivated influenza vaccine now.
C. Give a live attenuated intranasal influenza vaccine.
D. Defer influenza vaccination until after pulmonary
rehabilitation.
Correct Answer
B
Rationales
Correct: Annual inactivated influenza vaccination is
recommended for adults ≥65 and those with chronic pulmonary
disease each season to reduce morbidity and mortality; prior-
season vaccination does not provide adequate protection for
the new season.
A: Incorrect — prior year vaccination does not protect against
new circulating strains; annual vaccination is indicated.
C: Incorrect — live attenuated intranasal vaccine is generally not
recommended for adults ≥50 or for those with chronic
cardiopulmonary disease.
D: Incorrect — deferral is unnecessary and would delay
protective immunization during influenza season.
Teaching Point
,Give annual inactivated influenza vaccine to older adults and
those with chronic lung disease.
Citation (Simplified APA)
Clinical guidelines (CDC ACIP; USPSTF) and NCLEX-RN 2025 Test
Plan (guideline consensus through 2024).
2)
Reference — Topic: Disease Prevention & Health Promotion —
Section: Cancer Screening (colorectal screening decision-
making)
Question Stem
A 52-year-old woman with no family history of colorectal cancer
asks about screening. She prefers noninvasive testing. Which
approach best balances efficacy and patient preference?
Options
A. Recommend no screening until age 60 because she’s
asymptomatic.
B. Recommend annual high-sensitivity fecal immunochemical
testing (FIT) or a colonoscopy every 10 years.
C. Recommend flexible sigmoidoscopy only every 5 years.
D. Recommend CT colonography every 3 years as the primary
option.
Correct Answer
B
Rationales
Correct: USPSTF-based recommendations offer multiple
, acceptable options for average-risk adults starting at 45–50;
annual high-sensitivity FIT or colonoscopy every 10 years both
provide effective screening, and FIT aligns with her noninvasive
preference.
A: Incorrect — delaying screening past recommended initiation
increases risk of missed early lesions.
C: Incorrect — flexible sigmoidoscopy alone is less
comprehensive; colonoscopy or FIT are preferred options.
D: Incorrect — CT colonography is an alternative but is typically
every 5 years and involves radiation and follow-up colonoscopy
if positive.
Teaching Point
Offer shared-decision colorectal screening options (FIT annually
or colonoscopy every 10 years).
Citation (Simplified APA)
USPSTF and colorectal screening guideline consensus through
2024.
3)
Reference — Topic: Disease Prevention & Health Promotion —
Section: Cardiovascular Risk Reduction (primary prevention
statin use)
Question Stem
A 57-year-old man has an LDL-C of 150 mg/dL, treated
hypertension, and a 10-year ASCVD risk of 12%. He asks about
starting a statin for primary prevention. What is the best